Moleculin Biotech, Inc.
XNAS:MBRX
7.5
$76.93 - 26.00
$7.14 - 1.00
$6.88
$7.65
$7.65
$7.71
91.25
6.01
79211
154421.78
49793200
Chart
TendieTensor AI Analysis
Company
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
Fundamentals
17
-0.120000
-0.532500
-17
100
BBG00B9T47L9
BBG00B9T47N7
49.50M
49.50M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own MBRX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.